Ripertamab (SCT400) is a recombinant, human-mouse chimeric anti-CD20 IgG1kappa mAb. Ripertamab can be used for the research of hematological malignancies, including non-Hodgkins lymphoma (NHL).
Purity:
>95.0%
CAS Number:
[2249927-04-4]
Target:
CD20
* VAT and and shipping costs not included. Errors and price changes excepted